• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰高血糖素受体的突变分析:与血管活性肠肽(VIP)/垂体腺苷酸环化酶激活肽(PACAP)/促胰液素受体在识别配体第三个残基方面的相似性。

Mutational analysis of the glucagon receptor: similarities with the vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating peptide (PACAP)/secretin receptors for recognition of the ligand's third residue.

作者信息

Perret Jason, Van Craenenbroeck Mélanie, Langer Ingrid, Vertongen Pascale, Gregoire Françoise, Robberecht Patrick, Waelbroeck Magali

机构信息

Department of Biochemistry and Nutrition, School of Medicine, Université Libre de Bruxelles, Bât G/E, CP 611, 808 Route de Lennik, B-1070 Bruxelles, Belgium.

出版信息

Biochem J. 2002 Mar 1;362(Pt 2):389-94. doi: 10.1042/0264-6021:3620389.

DOI:10.1042/0264-6021:3620389
PMID:11853547
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1222399/
Abstract

Receptor recognition by the Asp(3) residues of vasoactive intestinal peptide and secretin requires the presence of a lysine residue close to the second transmembrane helix (TM2)/first extracellular loop junction and an ionic bond with an arginine residue in TM2. We tested whether the glucagon Gln(3) residue recognizes the equivalent positions in its receptor. Our data revealed that the binding and functional properties of the wild-type glucagon receptor and the K188R mutant were not significantly different, whereas all agonists had markedly lower potencies and affinities at the I195K mutated receptor. In contrast, glucagon was less potent and the Asp(3)-, Asn(3)- and Glu(3)-glucagon mutants were more potent and efficient at the double-mutated K188R/I195K receptor. Furthermore, these alterations were selective for position 3 of glucagon, as shown by the functional properties of the mutant Glu(9)- and Lys(15)-glucagon. Our results suggest that although the Gln(3) residue of glucagon did not interact with the equivalent binding pocket as the Asp(3) residue of vasoactive intestinal peptide or secretin, the Asp(3)-glucagon analogue was able to interact with position 188 of the K188R/I195K glucagon receptor. Nevertheless, the Gln(3) side chain of glucagon probably binds very close to this region in the wild-type receptor.

摘要

血管活性肠肽和促胰液素的天冬氨酸(Asp)3残基对受体的识别需要靠近第二个跨膜螺旋(TM2)/第一个细胞外环连接点处存在一个赖氨酸残基,以及与TM2中的一个精氨酸残基形成离子键。我们测试了胰高血糖素的谷氨酰胺(Gln)3残基是否识别其受体中的等效位置。我们的数据显示,野生型胰高血糖素受体和K188R突变体的结合和功能特性没有显著差异,而所有激动剂在I195K突变受体上的效力和亲和力均明显较低。相反,胰高血糖素效力较低,而天冬氨酸(Asp)3-、天冬酰胺(Asn)3-和谷氨酸(Glu)3-胰高血糖素突变体在双突变K188R/I195K受体上效力更高且更有效。此外,这些改变对胰高血糖素的3位具有选择性,如突变型谷氨酸(Glu)9-和赖氨酸(Lys)15-胰高血糖素的功能特性所示。我们的结果表明,尽管胰高血糖素的谷氨酰胺(Gln)3残基不像血管活性肠肽或促胰液素的天冬氨酸(Asp)3残基那样与等效结合口袋相互作用,但天冬氨酸(Asp)3-胰高血糖素类似物能够与K188R/I195K胰高血糖素受体的188位相互作用。然而,胰高血糖素的谷氨酰胺(Gln)3侧链可能在野生型受体中与该区域非常接近地结合。

相似文献

1
Mutational analysis of the glucagon receptor: similarities with the vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating peptide (PACAP)/secretin receptors for recognition of the ligand's third residue.胰高血糖素受体的突变分析:与血管活性肠肽(VIP)/垂体腺苷酸环化酶激活肽(PACAP)/促胰液素受体在识别配体第三个残基方面的相似性。
Biochem J. 2002 Mar 1;362(Pt 2):389-94. doi: 10.1042/0264-6021:3620389.
2
Identification of secretin, vasoactive intestinal peptide and glucagon binding sites: from chimaeric receptors to point mutations.促胰液素、血管活性肠肽和胰高血糖素结合位点的鉴定:从嵌合受体到点突变
Biochem Soc Trans. 2002 Aug;30(4):437-41. doi: 10.1042/bst0300437.
3
Interaction of amino acid residues at positions 8-15 of secretin with the N-terminal domain of the secretin receptor.促胰液素8-15位氨基酸残基与促胰液素受体N端结构域的相互作用。
Eur J Biochem. 1996 Jul 15;239(2):349-55. doi: 10.1111/j.1432-1033.1996.0349u.x.
4
Effect of introduction of an arginine16 in VIP, PACAP and secretin on ligand affinity for the receptors.在血管活性肠肽(VIP)、垂体腺苷酸环化酶激活肽(PACAP)和促胰液素中引入精氨酸16对配体与受体亲和力的影响。
Biochim Biophys Acta. 1996 Dec 12;1314(3):267-73. doi: 10.1016/s0167-4889(96)00106-1.
5
Role of second extracellular loop in the function of human vasoactive intestinal polypeptide/pituitary adenylate cyclase activating polypeptide receptor 1 (hVPAC1R).第二个细胞外环在人血管活性肠肽/垂体腺苷酸环化酶激活多肽受体1(hVPAC1R)功能中的作用。
J Mol Neurosci. 2000 Jun;14(3):137-46. doi: 10.1385/JMN:14:3:137.
6
Properties of the pituitary adenylate cyclase-activating polypeptide I and II receptors, vasoactive intestinal peptide1, and chimeric amino-terminal pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal peptide1 receptors: evidence for multiple receptor states.垂体腺苷酸环化酶激活多肽I和II受体、血管活性肠肽1以及嵌合氨基末端垂体腺苷酸环化酶激活多肽/血管活性肠肽1受体的特性:多种受体状态的证据
Mol Pharmacol. 1996 Dec;50(6):1596-604.
7
Receptors for VIP, PACAP, secretin, GRF, glucagon, GLP-1, and other members of their new family of G protein-linked receptors: structure-function relationship with special reference to the human VIP-1 receptor.
Ann N Y Acad Sci. 1996 Dec 26;805:94-109; discussion 110-1. doi: 10.1111/j.1749-6632.1996.tb17476.x.
8
Mutational analysis of the human vasoactive intestinal peptide receptor subtype VPAC(2): role of basic residues in the second transmembrane helix.人血管活性肠肽受体亚型VPAC(2)的突变分析:第二个跨膜螺旋中碱性残基的作用
Br J Pharmacol. 2001 Aug;133(8):1249-54. doi: 10.1038/sj.bjp.0704195.
9
Vasoactive intestinal peptide modification at position 22 allows discrimination between receptor subtypes.第22位的血管活性肠肽修饰可区分受体亚型。
Eur J Pharmacol. 1998 May 1;348(1):95-9. doi: 10.1016/s0014-2999(98)00133-2.
10
A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.克隆的蛙血管活性肠肽/垂体腺苷酸环化酶激活肽受体具有哺乳动物中VPAC1和VPAC2受体的药理学及组织分布特征。
Endocrinology. 1999 Mar;140(3):1285-93. doi: 10.1210/endo.140.3.6576.

引用本文的文献

1
Cryo-EM structure of the activated GLP-1 receptor in complex with a G protein.与G蛋白复合物结合的活化胰高血糖素样肽-1受体的冷冻电镜结构
Nature. 2017 Jun 8;546(7657):248-253. doi: 10.1038/nature22394. Epub 2017 May 24.
2
Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes.胰高血糖素样肽-1及其B类G蛋白偶联受体:通往治疗成功的漫长征程。
Pharmacol Rev. 2016 Oct;68(4):954-1013. doi: 10.1124/pr.115.011395.
3
Structural Determinants of Binding the Seven-transmembrane Domain of the Glucagon-like Peptide-1 Receptor (GLP-1R).胰高血糖素样肽-1受体(GLP-1R)七跨膜结构域结合的结构决定因素
J Biol Chem. 2016 Jun 17;291(25):12991-3004. doi: 10.1074/jbc.M116.721977. Epub 2016 Apr 8.
4
Use of Cysteine Trapping to Map Spatial Approximations between Residues Contributing to the Helix N-capping Motif of Secretin and Distinct Residues within Each of the Extracellular Loops of Its Receptor.利用半胱氨酸捕获技术绘制促胰液素螺旋N端封帽基序中残基与受体每个细胞外环内不同残基之间的空间近似关系。
J Biol Chem. 2016 Mar 4;291(10):5172-84. doi: 10.1074/jbc.M115.706010. Epub 2016 Jan 6.
5
The peptide agonist-binding site of the glucagon-like peptide-1 (GLP-1) receptor based on site-directed mutagenesis and knowledge-based modelling.基于定点诱变和知识建模的胰高血糖素样肽-1(GLP-1)受体的肽激动剂结合位点
Biosci Rep. 2015 Nov 23;36(1):e00285. doi: 10.1042/BSR20150253.
6
Transmembrane signal transduction by peptide hormones via family B G protein-coupled receptors.肽类激素通过B族G蛋白偶联受体进行跨膜信号转导。
Front Pharmacol. 2015 Nov 5;6:264. doi: 10.3389/fphar.2015.00264. eCollection 2015.
7
Conformational states of the full-length glucagon receptor.全长胰高血糖素受体的构象状态
Nat Commun. 2015 Jul 31;6:7859. doi: 10.1038/ncomms8859.
8
Ligand binding pocket formed by evolutionarily conserved residues in the glucagon-like peptide-1 (GLP-1) receptor core domain.由胰高血糖素样肽-1(GLP-1)受体核心结构域中进化保守残基形成的配体结合口袋。
J Biol Chem. 2015 Feb 27;290(9):5696-706. doi: 10.1074/jbc.M114.612606. Epub 2015 Jan 5.
9
Insights into the structure of class B GPCRs.B 类 G 蛋白偶联受体结构研究进展。
Trends Pharmacol Sci. 2014 Jan;35(1):12-22. doi: 10.1016/j.tips.2013.11.001. Epub 2013 Dec 18.
10
Structural and functional insights into the juxtamembranous amino-terminal tail and extracellular loop regions of class B GPCRs.对B类G蛋白偶联受体近膜氨基末端尾部和细胞外环区域的结构与功能的见解
Br J Pharmacol. 2014 Mar;171(5):1085-101. doi: 10.1111/bph.12293.

本文引用的文献

1
Mutational analysis of the human vasoactive intestinal peptide receptor subtype VPAC(2): role of basic residues in the second transmembrane helix.人血管活性肠肽受体亚型VPAC(2)的突变分析:第二个跨膜螺旋中碱性残基的作用
Br J Pharmacol. 2001 Aug;133(8):1249-54. doi: 10.1038/sj.bjp.0704195.
2
Conformation of a peptide ligand bound to its G-protein coupled receptor.与G蛋白偶联受体结合的肽配体的构象。
Nat Struct Biol. 2001 Feb;8(2):161-5. doi: 10.1038/84159.
3
Two basic residues of the h-VPAC1 receptor second transmembrane helix are essential for ligand binding and signal transduction.人血管活性肠肽1型受体(h-VPAC1受体)第二个跨膜螺旋的两个碱性残基对于配体结合和信号转导至关重要。
J Biol Chem. 2001 Jan 12;276(2):1084-8. doi: 10.1074/jbc.M007696200.
4
Selective stabilization of the high affinity binding conformation of glucagon receptor by the long splice variant of Galpha(s).
J Biol Chem. 2000 Jul 14;275(28):21631-8. doi: 10.1074/jbc.M002093200.
5
Role of charged amino acids conserved in the vasoactive intestinal polypeptide/secretin family of receptors on the secretin receptor functionality.血管活性肠肽/促胰液素受体家族中保守的带电荷氨基酸对促胰液素受体功能的作用。
Peptides. 1999;20(10):1187-93. doi: 10.1016/s0196-9781(99)00122-9.
6
Interaction of lipophilic VIP derivatives with recombinant VIP1/PACAP and VIP2/PACAP receptors.亲脂性血管活性肠肽衍生物与重组血管活性肠肽1/垂体腺苷酸环化酶激活肽及血管活性肠肽2/垂体腺苷酸环化酶激活肽受体的相互作用
Eur J Pharmacol. 1998 Jul 31;354(1):105-11. doi: 10.1016/s0014-2999(98)00435-x.
7
Contribution of the second transmembrane helix of the secretin receptor to the positioning of secretin.促胰液素受体的第二个跨膜螺旋对促胰液素定位的作用。
FEBS Lett. 1998 Mar 13;424(3):207-10. doi: 10.1016/s0014-5793(98)00175-6.
8
In vitro properties of a high affinity selective antagonist of the VIP1 receptor.血管活性肠肽1型受体高亲和力选择性拮抗剂的体外特性
Peptides. 1997;18(10):1555-60. doi: 10.1016/s0196-9781(97)00230-1.
9
Transmembrane residues of the parathyroid hormone (PTH)/PTH-related peptide receptor that specifically affect binding and signaling by agonist ligands.甲状旁腺激素(PTH)/PTH相关肽受体的跨膜残基,其特异性影响激动剂配体的结合和信号传导。
J Biol Chem. 1996 May 31;271(22):12820-5. doi: 10.1074/jbc.271.22.12820.
10
Lysine 173 residue within the first exoloop of rat secretin receptor is involved in carboxylate moiety recognition of Asp 3 in secretin.大鼠促胰液素受体第一个胞外环内的赖氨酸173残基参与促胰液素中天冬氨酸3的羧基部分识别。
Biochem Biophys Res Commun. 1996 Jan 26;218(3):842-6. doi: 10.1006/bbrc.1996.0150.